Objective: To determine the effect of neonatal and maternal blood group on the mortality risk from necrotizing enterocolitis (NEC).
Introduction
Necrotizing enterocolitis (NEC) is a life-threatening disease of uncertain etiology that affects up to 10% of extremely-lowbirthweight (ELBW) neonates and carries with it a high mortality rate. 1 This disease process is multifactorial and thought to encompass factors such as ischemia, infection, inflammation, endothelial injury and immune dysfunction. 1, 2 Numerous studies have attempted to identify biomarkers to predict the occurrence and/or severity of NEC, but to date there are no reliable indicators.
Several recent studies though have detected a temporal relationship between the administration of red blood cells (RBCs) and the onset of NEC in preterm neonates. 1, 3 Transfusion of RBCs is commonplace in the neonatal intensive care unit (NICU), especially among the extremely-low-birthweight neonates. Common practice in many NICUs is to transfuse RBCs from dedicated aliquots of group O, Rh-negative units, regardless of the neonate's blood type, in order to minimize the neonate's antibody exposure. However, the impact that ABO blood group antigens (or their isoagglutinins) might have on the development of NEC has not been previously investigated. In this study we set out to determine if there was a relationship between neonatal and maternal blood groups and the neonate's mortality risk from NEC.
Methods
Loyola University Medical Center is a perinatal referral center with a 50-bed level III NICU that admits both inborn and outborn neonates. After obtaining IRB approval, a retrospective chart review was conducted of all neonates admitted to our NICU from January 1, 1986 through July 1, 2010 in order to identify neonates diagnosed with NEC, stage IIa or greater, by modified Bell's staging criteria. 4 Infants who had spontaneous intestinal perforation were not classified as stage III NEC or included in the study. The individual charts of those neonates with a NEC diagnosis were reviewed to determine maternal blood group, neonatal blood group, gestational age, date of birth, transfusion history, surgical history and date of either death or discharge from the NICU. Timing of blood transfusions in these neonates could not be accurately determined from the chart review, but data were collected regarding the number of transfusions received by the neonates before the onset of NEC. Survival times, which were defined as the time from birth to the time of either discharge or death, were also calculated.
Comparisons of gestational age and birth weight (both as continuous variables) to mortality from NEC were performed using the Mann-Whitney U-test. Prediction of the probability of death from NEC (and subsequent odds ratios) was calculated using logistic regression models. Survival analyses were performed using Kaplan-Meier plots and Cox models.
Results
Of the 466 neonates identified as having been diagnosed with NEC during the 24 year study period, only 276 of the neonates had complete chart data and a NEC diagnosis of stage IIa or greater; thus, data analysis was performed using only these 276 neonates. There was no statistically significant difference between gender among those neonates that died from NEC versus those that survived, but neonates who died from NEC had a significantly lower birthweight and lower gestational age (Table 1) . Initial analysis of the data revealed no statistical difference based on Rh classification, therefore neonates were classified strictly based on their blood group. Blood group distribution among our neonates was similar to that of the population (43% group O, 30% group A, 20% group B and 7% group AB compared with national averages of 45% group O, 40% group A, 11% group B and 4% group AB) ( Table 1) . 5 When survival was analyzed based solely on the neonatal blood group, neonates with group AB blood were significantly more likely to die from NEC (HR 2.87; 95% CI 1.40 to 5.89; P ¼ 0.003) ( Figure 1 ). The significant difference in survival within the group of AB neonates is not only due to the disproportionate frequency of their demise (43%), but also to their short survival times. Neonates of all other blood groups tend to show very similar survival curves; as a result, AB neonates were significantly less likely to survive from NEC even when compared with each of the other individual blood groups (Kaplan-Meier P ¼ 0.024; Figure 2 ).
Comparison of neonatal survival from NEC was also performed taking into account the maternal blood group. Again, neonates with AB blood group remained at a significantly increased risk of mortality from NEC, but the risk was highest if they were born to a mother with group A or AB blood (HR 2.48; 95% CI 1.06 to 5.81; P ¼ 0.030) ( Table 2 ).
In addition, separate survival analyses were performed to confirm the impact of stage 2-3 NEC and surgery on survival from NEC. In our data, neonates with stage 3 NEC were five times more likely to die from NEC than their stage 2 counterparts (HR 5.03, 95% CI 2.82 to 9.01; P<0.0001). Furthermore, those neonates who required surgery for NEC were four times more likely to die from NEC compared with those neonates who did not require surgery (HR 4.18, 95% CI 2.38 to 7.30; P<0.0001).
Separate analyses were performed to attempt to determine the impact that RBC transfusion has on neonatal from NEC. Of the 276 neonates included in the analysis, 168 neonates had at least (Table 2) .
Discussion
Data analysis from our experience with NEC over the past 24 years demonstrates a significant influence of both maternal and neonatal blood groups on a neonate's mortality risk from NEC. The underlying relationship between blood group and mortality from NEC is likely a multifactorial one involving not only neonatal blood group antigens, but also the passive transfer of isoagglutinins from both the mother and from postnatal exposure to blood products. Standard transfusion practice in our NICU is to transfuse neonates with group O, Rh-negative RBCs divided into aliquots from a dedicated unit. All our neonates receive blood that is CMV-seronegative, irradiated and leukofiltered before transfusion; transfusions are dosed at 15 ml kg À1 and given over a period of 4 h. Our neonates are allowed to continue to feed during transfusion of blood products. Group O RBCs contain a small amount of isoagglutinins in the supernatant and serves as a second source (maternal transfer of isoagglutinins being the first source) of passive exposure of the neonate to anti-A and anti-B antibodies. Although thought to be present in such minute quantities as to not pose any problems to the patient, it is possible that the interaction of these passively transferred isoagglutinins in extremely-lowbirthweight neonates with compromised immune systems may trigger an immune response that has as its target an immature gastrointestinal system. This possible scenario may then begin a series of gastrointestinal injuries that subsequently manifests as NEC.
Multiple studies of neonatal meconium have shown that high molecular weight glycoproteins known as mucins contain many oligosaccharides with blood group antigen determinants. 6, 7 Mucins are produced by the goblet cells and epithelial cells of the intestinal tract and are thought to serve a protective role to the intestinal mucosa. Robbe-Masselot, et al. 7 found that unlike adults who express blood group determinants only in the proximal colon, fetal intestines have blood group determinants expressed in all parts of the small and large intestine. Postnatal exposure to bacterial colonization and other environmental stimuli are thought to be responsible for the conversion of blood group antigen expression in the intestine from that of a fetal pattern to the adult pattern. 7 Although the prior studies have shown blood group antigen expression on the epithelium, no studies have looked for expression on the endothelial surfaces of intestinal mucosa. It is possible that the expression of blood group antigens on the endothelium of intestinal mucosa of neonates makes their intestinal mucosa more susceptible to injury from passively acquired anti-A and anti-B isoagglutinins from RBC transfusions.
This notion that passively transferred isoagglutinins may trigger NEC, potentially through interaction with the blood group determinant expression in the neonatal intestine is supported by a recent study by Figueras-Aloy, et al. 8 They noted that among the 11 infants with hyperbilirubinemia who developed NEC, 10 of the infants had recently received intravenous immunoglobulin (IVIG) shortly before the onset of NEC. As commercial IVIG preparations are comprised of immunoglobulins derived from large pools of plasma of many donors, including those who are Blood Group O, it Neonatal blood group and necrotizing enterocolitis T Thomson et al also contains measurable quantities of isoagglutinins. 9,10 However, unlike group O RBCs, there is a much higher concentration of isoagglutinins in IVIG. 9, 10 Although the authors didn't report the neonate's actual blood types, the higher concentration of isoagglutinins found in IVIG may explain in part the odds ratio of 31.66 associated with administration of IVIG and development of NEC. 8 Our study is limited by the inability to reliably ascertain from the old records the timing of prior blood transfusions in relationship to the development of NEC. As this was a retrospective study, we are also unable to look at any of the actual intestinal mucosa of those neonates with NEC to determine if their intestinal mucosa expressed the blood group antigen determinants and if there was any difference in expression in the affected area compared with other regions; Robbe-Masselot et al. 7 suggested that this transition from the uniform expression in the fetus to the differential expression in adults occurs after birth. We are planning a future study to see if there is differential blood group determinant expression on the intestinal mucosa of those infants that develop NEC compared with those without NEC.
Although NEC represents a multifactorial disease process with unclear etiology, it appears that a humoral immune reaction between blood group antigens on the neonatal gastrointestinal mucosa and passively transferred isoagglutinins may have a role. This is supported by and may explain the subset of patients who develop NEC in relation to blood transfusions. The presence of both A and B antigens in AB neonates presents an enhanced opportunity for immune reaction and may explain their significantly worse prognosis when they develop NEC. In light of these data, it may be prudent to change the standard transfusion practices in the NICU from that of administering aliquoted group O, Rh-negative RBCs to one in which the neonate is administered type-specific units. Although this will likely not eradicate NEC, it is an easily modifiable factor that may help to prevent those cases of NEC that develop in relation to the transfusion of blood products.
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